Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus

Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus

Abstract Background Pleural effusion in systemic lupus erythematous (SLE) is a common symptom, and recent studies demonstrated that IL-6 has a pivotal role in its pathogenesis. Case presentation We report a case of a 15 years old Caucasian boy with a history of persistent pleural effusion without lu...

Full description

Bibliographic Details
Main Authors: Arianna De Matteis, Emanuela Sacco, Camilla Celani, Andrea Uva, Virginia Messia, Rebecca Nicolai, Manuela Pardeo, Fabrizio De Benedetti, Claudia Bracaglia
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Pediatric Rheumatology Online Journal
Subjects:
JSLE (Juvenile-onset Systemic Lupus Erythematosus) - Pleural effusion
IL-6
Tocilizumab
Online Access:https://doi.org/10.1186/s12969-021-00635-w

Internet

https://doi.org/10.1186/s12969-021-00635-w

Similar Items